MENU
CLDI
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Calidi Biotherapeutics (CLDI) Ownership - Who owns Calidi Biotherapeutics?
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer... Show more
Profile
Industry
N/A
Address
4475 Executive Drive
Phone
N/A
Employees
41
Web
https://www.calidibio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
13.66M
P/E Ratio
N/A
Total Cash
1.9M
Projected Growth
N/A
Total Debt
9.02M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.07
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CLDI
Capitalization
13.7M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
1.9M
Total Cash/Share
0.07
Total Debt
9.02M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-10.28M
P/B Ratio
8.90
Cash Flow
N/A
Earnings
-1.04
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
0.19
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-23.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
87.65
Revenue To Assets
-221.41
Shares Held By Institutions
1.46M
Shares Outstanding - Current
25.9M
Total Liabilities
16.5M
Total Volume MTD
N/A
Value
1
Gain YTD
-49.478
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
4475 Executive Drive
Phone
N/A
Employees
41
Web
https://www.calidibio.com